142280 — Green Cross Medical Science Income Statement
0.000.00%
Last trade - 00:00
- KR₩85bn
- KR₩104bn
- KR₩94bn
- 39
- 29
- 23
- 16
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 94,085 | 113,377 | 101,675 | 113,109 | 94,011 |
Cost of Revenue | |||||
Gross Profit | 9,470 | 19,818 | 1,673 | 12,805 | 14,025 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 103,629 | 109,179 | 121,839 | 114,372 | 92,210 |
Operating Profit | -9,544 | 4,199 | -20,164 | -1,263 | 1,801 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -16,350 | 7,238 | -21,108 | -2,951 | 1,865 |
Provision for Income Taxes | |||||
Net Income After Taxes | -16,350 | 7,027 | -21,138 | -3,059 | 1,877 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -16,205 | 6,717 | -21,202 | -3,581 | 1,797 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -16,205 | 6,717 | -21,202 | -3,581 | 1,797 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1,006 | 305 | -1,007 | -170 | 85.6 |
Dividends per Share |